LogicBio Therapeutics, Inc. Debt to Equity Ratio 2018-2022 | LOGC
Current and historical debt to equity ratio values for LogicBio Therapeutics, Inc. (LOGC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. LogicBio Therapeutics, Inc. debt/equity for the three months ending September 30, 2022 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2022-09-30 | $0.02B | $0.02B | 1.45 |
| 2022-06-30 | $0.03B | $0.02B | 1.27 |
| 2022-03-31 | $0.03B | $0.03B | 1.08 |
| 2021-12-31 | $0.03B | $0.03B | 1.04 |
| 2021-09-30 | $0.03B | $0.04B | 0.76 |
| 2021-06-30 | $0.03B | $0.05B | 0.74 |
| 2021-03-31 | $0.02B | $0.05B | 0.36 |
| 2020-12-31 | $0.02B | $0.06B | 0.31 |
| 2020-09-30 | $0.02B | $0.02B | 0.88 |
| 2020-06-30 | $0.02B | $0.03B | 0.68 |
| 2020-03-31 | $0.02B | $0.03B | 0.45 |
| 2019-12-31 | $0.01B | $0.04B | 0.32 |
| 2019-09-30 | $0.01B | $0.05B | 0.26 |
| 2019-06-30 | $0.01B | $0.06B | 0.07 |
| 2019-03-31 | $0.00B | $0.07B | 0.05 |
| 2018-12-31 | $0.00B | $0.08B | 0.03 |
| 2018-09-30 | $0.04B | $-0.02B | -1.91 |
| 2018-06-30 | $0.00B | 0.00 | |
| 2018-03-31 | $0.00B | 0.00 | |
| 2017-09-30 | $0.00B | 0.00 | |
